Status:
COMPLETED
Safe Return to Play After ACL Reconstruction
Lead Sponsor:
Rothman Institute Orthopaedics
Conditions:
ACL Tear
Eligibility:
All Genders
15-35 years
Brief Summary
Recent studies report that as few as 44% of athletes undergoing ACL reconstruction were able to return to their prior level of competitive level of sports. Early return may predispose an individual to...
Eligibility Criteria
Inclusion
- All patients ages 15-35 undergoing primary ACL reconstruction
Exclusion
- patients who are undergoing revision ACL surgery
Key Trial Info
Start Date :
February 20 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2020
Estimated Enrollment :
222 Patients enrolled
Trial Details
Trial ID
NCT04827264
Start Date
February 20 2016
End Date
February 20 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States, 19107